Development of solid lipid nanoparticles as eschar delivery system for nitrofurazone using Taguchi design approach

International Journal of Research in Pharmaceutical Sciences

Volumn 1, Issue 4, 2010, Pages 466-472

  Zadeh, Behzad Sharif Makhmal ^a   Barati, Nastaran ^a   Hassani, Mohammad Hossin ^a   Rahim, Fakher ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Entrapment efficiency; Percutaneous absorption; SLN; Taguchi design

Indexed keywords

EID: 84863949033     PISSN: None     EISSN: 09757538     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bowler, P.G., Davis, B.J. The microbiology of acute and chronic wounds. Wounds. 1990; 11: 72-78.
2. Green, J.W., Wenzel, R.P. Post operative wound infec-tion: a controlled study of the increased duration of hospital stay and direct coast of hospitalization. Ann Surg 1977; 185: 264-268.
3. Kalariya, M., Padhi, B.K., Chougule, M., Misra, A. Me-thotrexate loaded solid lipid nanoparticles for topical treatment of psoriasis: F & clinical implication. Drug. Del. Tech. 2008; 13: 14-19.
4. Liedtke, S., Wissing, S.A., Muller, R.H., Mader, K. Influence of high pressure homogenization equipment on nanodispersion characteristics. Int. J. Pharm. 2000; 196: 183-185.
5. Lukoneski, G., Hoell, A., Dingler, A., Kranold, R., Pflegel, P. Fractual surface of solid lipid nanoparticles pro-ceed. Int Symp. Control. Rel. Bioact. Mater. 1997; 24: 631-632.
6. Monafo, W.W., Wes,t M.A. Current treatment recom-mendations for topical burn therapy. Drugs. 1990; (40): 364-373.
7. Muller, R.H., Mader, K., Gohla, S. Solid nano particles for controlled drug delivery-a review of the state of the art. Eur. J. Pharm. Biopharm. 2000b; 50: 161-177.
8. Naoun, J.J, Roehl, K.R, Wolf, S.E., Herendon, D.N. The use of homograft compared to topical antimicrobial therapy in the treatment of second-degree burns of more than 40% total body surface area. Burns. 2004; (30): 548-551.
9. Panchagnula, R., Bokalial, R., Sharma, R., Khandavilli, S. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies. Int. J. Pharm. 2005; vol 293 (1-2): 213-223.
10. Pardeike, J., Hommoss, A., Muller, R.H. Lipid nanopar-ticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm. 2009; 366: 170-184.
11. Ross, D.A, Phipps, A.J., Clarke, J.A. The use of cerium nitrate-silver sulphadiazine a topical burn dressing. Br. J. Plast. Surg. 1993; 46 (7): 582-4.
12. Saoto, E.B., Wissing, S.A., Barbosa, C.M., Muller, R.H. Development of a controlled release F based on SLN and NLC for topical clotrimazol delivery. Int. J. Pharm. 2004; 728 (1): 71-77.
13. Schafer-Korting, M., Mehnert, W., Korting, H.C. Lipid nano particles for improved topical application for skin disease. Adv. Drug. Deli. Rev. 2007; 59: 427-443.
14. Schwartz, K. Burn wound infection. Eur. Med. J. 2002; 3: 1-9.
15. Stefanides, M.M, Copeland, C.E., Kominos, S.D., Yee, R.B. In vitro penetration of topical antiseptics through eschar of burn patient. Ann. Surg. 1975; (183): 358-364.
16. Williams, W.G. Pathophysiology of burn wound. In: Herendon D.N (ed). Total Burn Care.; Susnders, Lon-don, 2002, PP:514-522.
17. Zur Muhlen, A., Mehnert, W. Drug incorporation and delivery of prednisolone loaded SLN. Proceed, first world meeting APGI/Apr, Budapest, 1995; pp:455.
18. Zur Muhlen, A., Schwarz, C., Mehnert, W. Solid lipid nanoparticles for controlled drug delivery-drug release and release mechanism. Eur. J. Pharm. Bio-pharm. 1998; 45: 149-155.